Literature DB >> 10649963

Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase.

T R Radabaugh1, H V Aposhian.   

Abstract

An arsenate (As(V)) reductase has been partially purified from human liver. Its apparent molecular mass is approximately 72 kDa. The enzyme required a thiol and a heat stable cofactor for activity. The cofactor is less than 3 kDa in size. The thiol requirement can be satisfied by dithiothreitol (DTT). However, the extent of stimulation of reductase activity by glutathione, thioredoxin, or reduced lipoic acid was negligible compared to that of DTT. The heat stable cofactor does not appear to be Cu(2+), Mn(2+), Zn(2+), Mg(2+), or Ca(2+). The enzyme does not reduce monomethylarsonic acid (MMA(V)). The isolation and characterization of this enzyme demonstrates that in humans, the reduction of arsenate to arsenite is enzymatically catalyzed and is not solely the result of chemical reduction by glutathione as has been proposed in the past.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10649963     DOI: 10.1021/tx990115k

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  16 in total

Review 1.  Microbial methylation of metalloids: arsenic, antimony, and bismuth.

Authors:  Ronald Bentley; Thomas G Chasteen
Journal:  Microbiol Mol Biol Rev       Date:  2002-06       Impact factor: 11.056

Review 2.  Non-redox cycling mechanisms of oxidative stress induced by PM metals.

Authors:  James M Samet; Hao Chen; Edward R Pennington; Philip A Bromberg
Journal:  Free Radic Biol Med       Date:  2019-12-23       Impact factor: 7.376

3.  Adventitious arsenate reductase activity of the catalytic domain of the human Cdc25B and Cdc25C phosphatases.

Authors:  Hiranmoy Bhattacharjee; Ju Sheng; A Abdul Ajees; Rita Mukhopadhyay; Barry P Rosen
Journal:  Biochemistry       Date:  2010-02-02       Impact factor: 3.162

4.  Effect of sulfide on the cytotoxicity of arsenite and arsenate in human hepatocytes (HepG2) and human urothelial cells (UROtsa).

Authors:  Sinikka Hinrichsen; Regina Lohmayer; Ricarda Zdrenka; Elke Dopp; Britta Planer-Friedrich
Journal:  Environ Sci Pollut Res Int       Date:  2014-05-01       Impact factor: 4.223

5.  Ameliorative Effects of Caffeic Acid Against Arsenic-Induced Testicular Injury in Mice.

Authors:  Maryam Dehdashti Moghadam; Hasan Baghshani; Hamideh Ghodrati Azadi; Zahra Moosavi
Journal:  Biol Trace Elem Res       Date:  2021-01-04       Impact factor: 3.738

Review 6.  Oxidative mechanism of arsenic toxicity and carcinogenesis.

Authors:  Honglian Shi; Xianglin Shi; Ke Jian Liu
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

7.  Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments.

Authors:  Michael R Easterling; Miroslav Styblo; Marina V Evans; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-06       Impact factor: 2.745

8.  Influence of GSTT1 Genetic Polymorphisms on Arsenic Metabolism.

Authors:  Molly L Kile; E Andres Houseman; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Golam Mostofa; Yu-Mei Hsueh; David C Christiani
Journal:  J Indian Soc Agric Stat       Date:  2013-08-01

9.  Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione.

Authors:  Siucheong Yan; Fei Li; Keyang Ding; Hongzhe Sun
Journal:  J Biol Inorg Chem       Date:  2003-06-21       Impact factor: 3.358

10.  Immunotoxicity and biodistribution analysis of arsenic trioxide in C57Bl/6 mice following a 2-week inhalation exposure.

Authors:  Scott W Burchiel; Leah A Mitchell; Fredine T Lauer; Xi Sun; Jacob D McDonald; Laurie G Hudson; Ke Jian Liu
Journal:  Toxicol Appl Pharmacol       Date:  2009-10-02       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.